Latest stories on ADCT
ADC Therapeutics provides Zynlonta updates in Japan
The Fly56 · neutralproduct/pr
ADC Therapeutics Announces ZYNLONTA® Updates in Japan
PR Newswire61 · neutralproduct/pr
ADC Therapeutics SA (ADCT) files 8-K
SEC 8-K50 · neutralgeneral
ADC Therapeutics (ADCT) gains after $86.6M PIPE extends expected cash runway into 2029
MarketChameleon58 · neutralgeneral
ADC Therapeutics SA (ADCT) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference - Slideshow
Seeking Alpha55 · neutralgeneral
ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
PR Newswire55 · neutralgeneral
ADC Therapeutics (ADCT) Navigates FDA Setback While Cutting Its Losses
Yahoo Top34 · bearishearnings
ADC Therapeutics (ADCT) Q2 2026 Earnings Call Transcript
The Motley Fool34 · bearishearnings
Guggenheim cuts ADC Therapeutics stock price target on FDA concerns
Investing.com Analyst Ratings34 · bearishanalyst
ADC Therapeutics price target lowered to $5 from $10 at Guggenheim
The Fly32 · bearishanalyst
ADC Therapeutics reports Q2 adjusted EPS (11c) vs. (25c) last year
The Fly56 · neutralearnings
ADC Therapeutics signals cash runway into 2028 while assessing LOTIS-5 regulatory path forward
Seeking Alpha58 · neutralgeneral
ADC Therapeutics SA (ADCT) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
ADC Therapeutics Reports Q2 2026 Results, Reassesses ZYNLONTA Path
TipRanks48 · neutralearnings
ADC Therapeutics SA (ADCT) files 8-K
SEC 8-K50 · neutralgeneral
ADC Therapeutics Non-GAAP EPS of -$0.11, revenue of $19.25M beats by $0.35M
Seeking Alpha56 · neutralearnings
ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates
PR Newswire55 · neutralearnings
ADC Therapeutics Q2 Earnings Preview
Seeking Alpha48 · neutralearnings
ADC Therapeutics to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026
PR Newswire50 · neutralgeneral
ADC Therapeutics Grants One-Time Retention Awards to Executives
TipRanks50 · neutralgeneral
ADC Therapeutics SA (ADCT) files 8-K
SEC 8-K50 · neutralgeneral
ADC Therapeutics Announces New Employee Inducement Grant | ADCT Stock News
StockTitan50 · neutralgeneral
ADC Therapeutics Announces New Employee Inducement Grant
PR Newswire50 · neutralgeneral
ADC Therapeutics Announces Completion of Enrollment in LOTIS-7 Phase 1b ZYNLONTA® Combination Trial
PR Newswire63 · neutralproduct/pr
ADC Therapeutics Announces ZYNLONTA-Focused Strategic Reorganization
TipRanks55 · neutralgeneral